Hyderabad, India-based pharmaceutical company Granules India launched its new packaging facility through its Granules Consumer Health (GCH) step-down subsidiary, in Manassas, Virginia. The facility was inaugurated by India’s Ambassador to the U.S., Taranjit Singh Sandhu.
Granules invested more than $100 million in this unit. Spread over 79,000ft², the facility is equipped with packaging lines and clean rooms to package and ship prescription and over-the-counter products across the U.S. market.
Dr. Krishna Prasad Chigurupati, chairman and managing director, Granules India said, “Granules Consumer Health’s packaging facility will improve resilience in our supply chain as well as our reaction time. The facility will enable us to meet fast-moving consumer shifts as well as reduce lead times for critical prescription products that are in shortage.”
The addition of a U.S. packaging facility will result in Granules being among the few pharmaceutical companies to be vertically integrated from API to packaging,
Select USA, which is led by the U.S. Department of Commerce and focuses on facilitating job-creating business investment in the country, congratulated Granules India Ltd on the opening of its new facility in Virginia.
Established in 1991, Granules India distributes products to customers in regulated and semi-regulated markets and has a global presence in more than 80+ countries with offices across India, the U.S., and UK. The company has seven manufacturing facilities, of which six are in India and one is in the U.S.
